Ekocorp

Ekocorp CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Ekocorp (EKOCORP.NL) as of Oct 23, 2026 is 976.08 %. In the previous year, CapEx to Operating Cash Flow Ratio was 976.08 % — a change of 0.00% (lower).

CapEx/OCF

976.08 %

YoY

0.00%

Last updated:

CapEx to Operating Cash Flow Ratio of Ekocorp is 2020 976.08 % . CapEx to Operating Cash Flow Ratio of Ekocorp was 2019 976.08 % . It decreases by 0.00% lower compared to the previous year.

The Ekocorp CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2015
-9.42 NGN
Jan 1, 2016
51.50 NGN
Jan 1, 2017
735.85 NGN
Jan 1, 2018
119.31 NGN
Jan 1, 2019
976.08 NGN
Jan 1, 2020
976.08 NGN
The Ekocorp CapEx/OCF history
YEARCapEx/OCFYoY
976.08 %0.00%
976.08 %+718.10%
119.31 %-83.79%
735.85 %+1,328.72%
51.50 %-646.95%
-9.42 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ekocorp Stock analysis

What does Ekocorp do? Ekocorp PLC provides healthcare services through its segments including standalone facilities, capitation models, and strategic business units such as general outpatients, nursing, intensive care, medical, obstetrics and gynaecology, paediatrics, radiology, and surgery. The company offers specialized medical services like dietician, diabetic nurse educator, foot care specialist, and consultant ophthalmologist. Its consultant services encompass general surgery, orthopaedic surgery, grammatology, otorhinolaryngology, audiology, speech therapy, dental surgery, ophthalmology, radiology, physical medicine (Physiotherapy), endoscopy, anaesthesia, obstetrics and gynaecology, radiotherapy, and oncology. Ekocorp also provides immunological screening services including thyroid antibodies, thyroid adrenal anti-nuclear antibodies, and paediatric endocrinology. The firm targets patients seeking specialized medical care and preventive health services. Its services are delivered through its healthcare delivery model focused on standard medical care and anchor services. Ekocorp's strategic business units serve diverse patient needs across various medical specialties. The company's offerings include both outpatient and inpatient care through its structured segments. Ekocorp PLC's revenue streams come from medical service fees charged to patients and healthcare providers. The company generates income through its consultant services, specialized medical care, and immunological screening services. Its business model relies on delivering high-quality healthcare services across multiple specialties to a broad patient base. The firm's segments operate under a unified healthcare delivery framework that supports its service offerings. Ekocorp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ekocorp stock

CapEx to Operating Cash Flow Ratio of Ekocorp is 976.08 % in 2020.

CapEx to Operating Cash Flow Ratio of Ekocorp changed from 976.08 % to 976.08 %, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Ekocorp since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Ekocorp with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ekocorp

All Key Metrics — Ekocorp